Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-b]pyridine anticancer compound

Tumor progression may be driven by a small subpopulation of cancer stem cells (CSCs characterized by CD44(+)/CD24(−) phenotype). We investigated the influence of a newly developed thienopyridine anticancer compound (3-amino-5-oxo-N-naphthyl-5,6,7, 8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide, 1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastelić, Angela, Čikeš Čulić, Vedrana, Režić Mužinić, Nikolina, Vuica-Ross, Milena, Barker, David, Leung, Euphemia Y, Reynisson, Jóhannes, Markotić, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359006/
https://www.ncbi.nlm.nih.gov/pubmed/28352152
http://dx.doi.org/10.2147/DDDT.S121122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359006/
https://www.ncbi.nlm.nih.gov/pubmed/28352152
http://dx.doi.org/10.2147/DDDT.S121122

Ejemplares similares